For years, the Chinese dairy industry has been defined by breakneck expansion and fierce price wars. However, as the domestic market enters a challenging cycle of oversupply and cautious consumer spending, Mengniu Dairy is signaling a strategic pivot from volume-chasing to margin-protecting. The company’s 2025 financial results, reporting a revenue of 82.25 billion RMB and a record-high gross margin of 39.9%, suggest that the giant is successfully insulating itself from the broader industry malaise through premiumization and operational discipline.
Central to this performance is the 'One Body, Two Wings' strategy implemented by CEO Gao Fei, who took the helm in 2024. While liquid milk remains the core 'body' of the business—accounting for nearly 80% of revenue—the growth engine is increasingly found in the 'wings' of specialized nutrition and international expansion. Segments such as cheese, milk powder, and ice cream all recorded double-digit growth, with the cheese division alone surging by 21%, bolstered by the market-leading position of its subsidiary, Milkground.
Mengniu’s evolution reflects a broader trend among Chinese consumer giants: the transition from being a commodity provider to a high-tech health and nutrition enterprise. By investing in 'deep processing'—producing high-value ingredients like lactoferrin and HMOs (human milk oligosaccharides)—Mengniu is moving up the value chain. This shift not only reduces dependence on volatile raw milk prices but also targets high-margin niches such as professional sports nutrition and specialized products for China’s rapidly aging population.
Internationalization has also emerged as a critical hedge against domestic saturation. The company’s Southeast Asian brand, Aice, has maintained a dominant market share in Indonesia while expanding into the Philippines and Vietnam. Meanwhile, its Australian operations through Bellamy’s and Burra Foods provide a strategic base for both premium consumer goods and B2B ingredients. This global footprint allows Mengniu to tap into emerging middle-class demand across the Global South while securing high-quality supply chains in Oceania.
Operationally, the 2025 report highlights a significant internal 'management revolution.' By digitalizing its supply chain from farm to fridge, Mengniu has slashed inventory cycles and administrative costs. Even as raw milk prices fluctuated, the company improved its 'self-hematopoiesis'—its internal cash-generating ability—reaching a record free cash flow of 6.3 billion RMB. This liquidity has enabled a robust three-year shareholder return plan, featuring consistent dividends and stock buybacks that have been warmly received by institutional investors.
Despite the positive numbers, the road ahead remains complex. The industry is grappling with a structural shift as the Chinese government prioritizes 'food security' and 'dairy revitalization' amid a declining birth rate. Mengniu’s gamble on specialized nutrition and 'eating milk' (processed products) rather than just 'drinking milk' is a direct response to these demographic headwinds. As the company looks toward 2026, its ability to maintain these record margins will depend on whether its high-tech nutritional products can truly become essential daily needs for a more discerning Chinese consumer.